Morgan Stanley Reaffirms Equal Weight Rating for Integral Ad Science (NASDAQ:IAS)

Morgan Stanley reaffirmed their equal weight rating on shares of Integral Ad Science (NASDAQ:IAS) in a report released on Tuesday, Marketbeat Ratings reports. They currently have a $12.00 price target on the stock, down from their prior price target of $18.00.

A number of other research firms have also recently commented on IAS. Oppenheimer cut their target price on Integral Ad Science from $25.00 to $20.00 and set an outperform rating on the stock in a research note on Wednesday, February 28th. Raymond James lowered Integral Ad Science from a strong-buy rating to an outperform rating and lowered their price target for the company from $20.00 to $16.00 in a report on Wednesday, February 28th. BMO Capital Markets lowered their price target on Integral Ad Science from $18.00 to $16.00 and set an outperform rating for the company in a report on Wednesday, February 28th. Truist Financial lowered their price target on Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a report on Wednesday, February 28th. Finally, Barclays lowered their price target on Integral Ad Science from $16.00 to $12.00 and set an equal weight rating for the company in a report on Monday. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of Moderate Buy and an average target price of $17.58.

Integral Ad Science Trading Down 2.9 %

IAS opened at $9.10 on Tuesday. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 227.56, a P/E/G ratio of 1.65 and a beta of 1.60. The stock’s 50 day moving average price is $11.42 and its 200-day moving average price is $13.04. Integral Ad Science has a one year low of $9.08 and a one year high of $20.88. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.21 and a current ratio of 3.21.

Integral Ad Science (NASDAQ:IAS) last released its earnings results on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The firm had revenue of $134.30 million for the quarter, compared to analysts’ expectations of $131.27 million. Integral Ad Science had a return on equity of 0.83% and a net margin of 1.53%. The company’s quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.07 earnings per share. On average, equities analysts forecast that Integral Ad Science will post 0.16 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 30,407 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $10.05, for a total transaction of $305,590.35. Following the completion of the sale, the chief executive officer now owns 188,678 shares in the company, valued at approximately $1,896,213.90. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CFO Tania Secor sold 6,570 shares of the stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $9.71, for a total transaction of $63,794.70. Following the completion of the sale, the chief financial officer now owns 230,888 shares in the company, valued at approximately $2,241,922.48. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Lisa Utzschneider sold 30,407 shares of the stock in a transaction on Monday, April 8th. The shares were sold at an average price of $10.05, for a total value of $305,590.35. Following the sale, the chief executive officer now owns 188,678 shares of the company’s stock, valued at approximately $1,896,213.90. The disclosure for this sale can be found here. Insiders sold a total of 80,195 shares of company stock worth $876,562 over the last 90 days. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

Several hedge funds and other institutional investors have recently made changes to their positions in IAS. Ameritas Investment Partners Inc. lifted its position in Integral Ad Science by 92.1% during the 1st quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock worth $34,000 after acquiring an additional 1,198 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new stake in Integral Ad Science during the 3rd quarter worth about $58,000. DekaBank Deutsche Girozentrale acquired a new stake in Integral Ad Science during the 3rd quarter worth about $62,000. Amalgamated Bank lifted its position in Integral Ad Science by 19.9% during the 3rd quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock worth $83,000 after acquiring an additional 1,156 shares during the period. Finally, Tower Research Capital LLC TRC lifted its position in Integral Ad Science by 493.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 8,581 shares of the company’s stock worth $62,000 after acquiring an additional 7,135 shares during the period. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.